Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 657 | $430,299,687 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
13 Jun 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 11 Jun 2024 | Sale | 1,743 | 1,016.04 | 1,770,958 | I |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 1,894 | 948.69 | 1,796,819 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,865 | 973.43 | 1,815,447 | D |
29 Dec 2023 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 27 Dec 2023 | Sale | 2,049 | 898 | 1,840,002 | D |
22 May 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | LAROSA JOSEPH J | EVP General Counsel and Secret | 21 May 2024 | Sale | 1,865 | 994.9 | 1,855,488 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 3,044 | 609.62 | 1,855,683 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,930 | 969.14 | 1,870,440 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 3,218 | 613.49 | 1,974,211 | D |
08 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 07 Nov 2022 | Sale | 2,782 | 746.56 | 2,076,930 | D |
29 Dec 2023 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 27 Dec 2023 | Sale | 2,448 | 856.71 | 2,097,226 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 2,534 | 844.27 | 2,139,380 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 2,283 | 981.52 | 2,240,810 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 14 May 2024 | Sale | 2,302 | 980.1 | 2,256,190 | D |
10 Jan 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 06 Jan 2023 | Sale | 3,070 | 747.14 | 2,293,720 | D |
25 Nov 2022 13:07 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 23 Nov 2022 | Sale | 3,124 | 739.48 | 2,310,136 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 30 Sep 2022 | Sale | 3,428 | 698 | 2,392,744 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 3,931 | 610.49 | 2,399,836 | D |
05 Oct 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 03 Oct 2022 | Sale | 3,346 | 724 | 2,422,504 | D |
08 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 06 Feb 2023 | Sale | 3,071 | 798 | 2,450,658 | D |
24 Apr 2023 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 21 Apr 2023 | Sale | 3,070 | 798.42 | 2,451,149 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 4,112 | 614.35 | 2,526,207 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 2,691 | 943.51 | 2,538,985 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 3,032 | 839.45 | 2,545,212 | D |
25 Jan 2024 16:18 | REGN | REGENERON PHARMACEUTICALS Inc | GOLDSTEIN JOSEPH L | Director | 23 Jan 2024 | Sale | 2,707 | 950 | 2,571,650 | D |
08 Aug 2022 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 04 Aug 2022 | Sale | 4,156 | 621.54 | 2,583,120 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 2,653 | 973.8 | 2,583,491 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 03 Oct 2022 | Sale | 3,612 | 718 | 2,593,416 | D |
08 Feb 2023 16:16 | REGN | REGENERON PHARMACEUTICALS Inc | GOLDSTEIN JOSEPH L | Director | 06 Feb 2023 | Sale | 3,613 | 800 | 2,890,400 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 3,127 | 950.43 | 2,971,995 | D |
08 Aug 2022 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 04 Aug 2022 | Sale | 4,887 | 620.85 | 3,034,094 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 3,213 | 968.44 | 3,111,598 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 3,387 | 968.43 | 3,280,072 | D |
23 Aug 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 22 Aug 2023 | Sale | 4,574 | 841.41 | 3,848,609 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 4,261 | 940.44 | 4,007,215 | D |
11 Aug 2022 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 09 Aug 2022 | Sale | 6,814 | 620.47 | 4,227,883 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 4,669 | 970.26 | 4,530,144 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 4,778 | 974.47 | 4,656,018 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 4,865 | 978.44 | 4,760,111 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 4,886 | 976.52 | 4,771,277 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 4,922 | 971.56 | 4,782,018 | D |
11 Aug 2022 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 09 Aug 2022 | Sale | 8,186 | 621.27 | 5,085,716 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 5,225 | 975.6 | 5,097,510 | D |
23 Aug 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 22 Aug 2023 | Sale | 6,309 | 840.53 | 5,302,904 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 23 Aug 2023 | Sale | 6,450 | 840.65 | 5,422,192 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 6,885 | 976.56 | 6,723,616 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 7,611 | 974.51 | 7,416,996 | D |
13 Jun 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 11 Jun 2024 | Sale | 7,321 | 1,015.28 | 7,432,865 | I |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 15 May 2024 | Sale | 7,864 | 979.05 | 7,699,249 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 9,242 | 975.48 | 9,015,386 | D |
17 May 2024 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 16 May 2024 | Sale | 9,501 | 969.39 | 9,210,174 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 9,851 | 977.42 | 9,628,564 | D |
08 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 06 Feb 2023 | Sale | 13,189 | 800.08 | 10,552,255 | I |
13 Jun 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 12 Jun 2024 | Sale | 14,879 | 1,015.3 | 15,106,649 | I |
04 Jan 2024 16:20 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 02 Jan 2024 | Sale | 16,848 | 900 | 15,163,200 | I |
01 May 2024 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 02 Jan 2024 | Sale | 16,848 | 900 | 15,163,200 | I |
17 May 2024 17:57 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 17 May 2024 | Sale | 22,687 | 979.22 | 22,215,564 | D |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 14 May 2024 | Sale | 22,698 | 979.16 | 22,224,974 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)